# FDA recall D-1182-2014

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2014-03-04.

## Product

Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx Only, 60 capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7542-06

## Reason for recall

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.

## Distribution

Nationwide, Guam, Puerto Rico, American Samoa, Virgin Islands.

## Key facts

- **Recall number:** D-1182-2014
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-03-04
- **Report date:** 2014-04-09
- **Termination date:** 2014-11-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Horsham, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1182-2014

## Citation

> AI Analytics. FDA recall D-1182-2014. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1182-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*